isosorbide-5-mononitrate has been researched along with Liver Cirrhosis in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (7.94) | 18.7374 |
1990's | 23 (36.51) | 18.2507 |
2000's | 28 (44.44) | 29.6817 |
2010's | 7 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SL; Chen, YP; Fan, YC; Ling, XF; Liu, WY; Pan, ZZ; Shi, KQ; Zheng, MH | 1 |
Aracil, C; Colomo, A; Gich, I; Graupera, I; Guarner, C; Hernández-Gea, V; Poca, M; Puente, A; Roque, M; Villanueva, C | 1 |
Appenrodt, B; Caca, K; Dollinger, M; Fimmers, R; Hoffmeister, A; Lorenzen, H; Lutz, H; Mengel, M; Panther, E; Rössle, M; Sauerbruch, T; Schepke, M; Schoo, R; Trebicka, J; Wiest, R; Zipprich, A | 1 |
Alvarado, E; Aracil, C; Ardevol, A; Colomo, A; Concepción, M; Graupera, I; Guarner, C; Hernandez-Gea, V; Miñana, J; Pavel, O; Poca, M; Puente, Á; Reñe, JM; Torras, X; Villanueva, C | 1 |
Aracil, C; Balanzo, J; Colomo, A; Gonzalez, B; Guarner, C; Lopez-Balaguer, JM; Piqueras, M; Torras, X; Villanueva, C | 1 |
Kumar, A; Sarin, SK; Sharma, BC; Sharma, P | 1 |
Ding, SH; Liu, J; Wang, JP | 1 |
Jo, YJ; Jun, DW; Kang, JS; Kim, EK; Kim, KT; Kim, SH; Park, JH; Park, YS; Son, BK | 1 |
Schepke, M | 1 |
Li, L; Li, Y; Yu, C | 1 |
Abu-Suboh, M; Armengol, JR; Augustin, S; Dot, J; Esteban, R; Genescà, J; González, A; Guardia, J; Pérez, M; Romero, A; Segarra, A | 1 |
Bissoli, F; Borroni, G; Cazzaniga, M; de Franchis, R; Lorenzano, E; Maggi, A; Panzeri, A; Salerno, F; Visentin, S | 1 |
Burroughs, AK; Gerunda, G; Goulis, J; Greenslade, L; Merkel, C; Patch, D; Sabin, CA | 1 |
Wang, H; Yuan, R; Zhang, Q | 1 |
Abraldes, JG; Bellis, L; Berzigotti, A; Bosch, J; García-Pagán, JC; Moitinho, E; Rodés, J | 1 |
Abraldes, JG; Bosch, J; Garcia-Pagan, JC; Rodés, J; Tarantino, I; Turnes, J | 1 |
Aracil, C; Balanzó, J; González, B; Guarner, C; Kolle, L; López-Balaguer, JM; Miñana, J; Soriano, G; Villanueva, C | 1 |
Bhaskar, ME | 1 |
Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Yang, YY | 1 |
Geĭnits, AV; Sapozhkova, LP; Sergienko, VB; Tadzhiev, IIa; Tadzhieva, NI; Topchiashvili, ZA; Tsodikov, GV | 1 |
Bolondi, L; Donati, G; Gaiani, S; Gramantieri, L; Leoni, S; Mancini, M; Piscaglia, F | 1 |
Balas, BI; Diculescu, M; Orban Schiopu, AM | 1 |
Chen, MX; Lin, XF; Lin, XY; Wu, JM; Wu, XL; Zhu, QH | 1 |
Gupta, R; Sarin, SK; Shahi, H; Wadhawan, M | 1 |
Argonz, J; Bosco, A; Dominguez, N; Fassio, E; Kravetz, D; Muñoz, A; Romero, G; Salgado, P; Suarez, A; Terg, R; Vulcano, C | 1 |
Laleman, W; Nevens, F | 1 |
Chan, HH; Chen, WC; Cheng, LC; Hsu, PI; Lai, KH; Lo, GH; Tsai, WL; Wang, HM | 1 |
Bosch, J; De Gottardi, A; Garcia-Pagan, JC | 1 |
Steudel, AT; Steudel, HC; Volkenandt, M | 1 |
Amodio, P; Angeli, P; Cavallarin, G; Donada, C; Enzo, E; Gatta, A; Marin, R; Merkel, C; Sebastianelli, G; Torboli, P | 1 |
Bellon, S; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Bolognesi, M; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Bangash, IH; Finlayson, ND; Hayes, PC; Jones, AL; Simpson, KJ; Walker, J | 1 |
Bosch, J; Cabré, E; Feu, F; Galán, A; García Pagán, JC; Gassull, MA; Morillas, RM; Planas, R; Quer, JC | 1 |
Bouchier, IA; Grose, RD; Hayes, PC; Plevris, JN; Redhead, DN | 1 |
Abbati, G; Cioni, G; Cristani, A; D'Alimonte, P; Romagnoli, R; Tincani, E; Ventura, E; Ventura, P; Vignoli, A | 1 |
Hayes, PC; Jones, AL | 1 |
Angelico, M; Bologna, E; Capocaccia, L; Carli, L; Gentile, S; Piat, C; Rinaldi, V | 1 |
Arroyo, V; Bosch, J; Claria, J; Feu, F; García-Pagán, JC; Ginès, A; Ginès, P; Rivera, F; Ruiz del Arbol, L; Salmerón, JM | 1 |
Bissoli, F; Borroni, G; Cazzaniga, M; Ceriani, R; deFranchis, R; Lorenzano, E; Salerno, F; Solenghi, D | 1 |
Bordas, JM; Bosch, J; Escorsell, A; Feu, F; García-Pagán, JC; Luca, A; Rodés, J | 1 |
Angeli, P; Bolognesi, M; Bombonato, G; Enzo, E; Gatta, A; Marin, R; Merkel, C; Sacerdoti, D | 1 |
Angelico, M; Capocaccia, L; Carli, L; Gentile, S; Piat, C | 1 |
Bordas, JM; Bosch, J; Escorsell, A; Feu, F; García-Pagán, JC; Ginès, A; Rodés, J | 1 |
Bouchier, IA; Hayes, PC; Stanley, AJ | 1 |
Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Bolondi, L; Gaiani, S; Gramantieri, L; Piscaglia, F; Serra, C; Siringo, S | 1 |
Burroughs, AK; Chin, J; Greenslade, L; McCormick, PA; McIntyre, N; Patch, D | 1 |
Amodio, P; Angeli, P; Bolognesi, M; Buonamico, P; Gatta, A; Merkel, C; Micotti, L; Sacerdoti, D; Sticca, A | 1 |
Amodio, P; Bolognesi, M; Cavallarin, G; Donada, C; Felder, M; Gatta, A; Marin, R; Mazzaro, C; Merkel, C; Sacerdoti, D; Sebastianelli, G; Torboli, P | 1 |
Bellini, B; Bighin, R; Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Herrera, JL; Zalepuga, R | 1 |
Chen, SD; Hsieh, JF; Lin, WY; Tsai, SC | 1 |
Abdurakhmanov, DT | 1 |
Albillos, A; Balanzó, J; Bosch, J; Calleja, JL; García-Pagán, JC; Genescà, J; González, A; Planas, R; Rodriguez, M; Ruiz-Del-Arbol, L; Solà, R; Vila, MC; Villanueva, C | 1 |
Bañares, R; Bosch, J; Bru, C; Echenagusia, A; Escorsell, A; García-Pagán, JC; Gilabert, R; Granados, A; Moitinho, E; Piqueras, B | 1 |
Bosch, J; Feu, F; García-Pagán, JC; Rodés, J | 1 |
Bosch, J; Bru, C; Feu, F; García-Pagán, JC; Navasa, M; Rodés, J; Ruiz del Arbol, L | 1 |
Bosch, J; Bru, C; Garcia-Pagán, JC; Navasa, M; Pizcueta, P; Rodés, J | 1 |
Chang, TT; Kong, CW; Lay, CS; Lee, FY; Lee, SD; Lin, HC; Lo, KJ; Tsai, YT; Wang, SS | 1 |
Bosch, J; Chesta, J; Navasa, M; Rodés, J | 1 |
Hayes, PC; Westaby, D; Williams, R | 1 |
Kanto, JH | 1 |
8 review(s) available for isosorbide-5-mononitrate and Liver Cirrhosis
Article | Year |
---|---|
Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysis.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Laser Coagulation; Ligation; Liver Cirrhosis; Portasystemic Shunt, Transjugular Intrahepatic; Randomized Controlled Trials as Topic; Sclerotherapy; Secondary Prevention; Treatment Outcome; Vasodilator Agents | 2013 |
Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review.
Topics: Adrenergic beta-Antagonists; Animals; Chi-Square Distribution; Combined Modality Therapy; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostatic Techniques; Hemostatics; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Odds Ratio; Recurrence; Risk Factors; Treatment Outcome | 2014 |
Efficacy of beta-adrenergic blocker plus 5-isosorbide mononitrate and endoscopic band ligation for prophylaxis of esophageal variceal rebleeding: a meta-analysis.
Topics: Adrenergic beta-Antagonists; Endoscopy; Esophageal and Gastric Varices; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents | 2009 |
[Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding].
Topics: Adrenergic beta-Antagonists; Anti-Bacterial Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Hormones; Humans; Hypertension, Portal; Infection Control; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Lypressin; Portal Pressure; Secondary Prevention; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2009 |
Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis.
Topics: Adrenergic beta-Antagonists; Comparative Effectiveness Research; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Primary Prevention; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Treatment Outcome; Vasodilator Agents | 2011 |
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Animals; Contraindications; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Forecasting; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Middle Aged; Nadolol; Portasystemic Shunt, Surgical; Portasystemic Shunt, Transjugular Intrahepatic; Practice Guidelines as Topic; Propranolol; Randomized Controlled Trials as Topic; Rats; Risk Factors; Risk Reduction Behavior; Splanchnic Circulation; Stents; Time Factors; Vascular Resistance; Vasodilator Agents | 2006 |
Review article: the modern management of portal hypertension--primary and secondary prophylaxis of variceal bleeding in cirrhotic patients.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Randomized Controlled Trials as Topic; Sclerotherapy; Secondary Prevention; Treatment Outcome | 2008 |
Organic nitrates in portal hypertension.
Topics: Animals; Collateral Circulation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Nitrates; Nitroglycerin; Vasodilator Agents | 1994 |
37 trial(s) available for isosorbide-5-mononitrate and Liver Cirrhosis
Article | Year |
---|---|
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Germany; Humans; Isosorbide Dinitrate; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide Donors; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Prospective Studies; Prosthesis Design; Quality of Life; Recurrence; Stents; Time Factors; Treatment Outcome; Vasodilator Agents; Venous Pressure | 2015 |
A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Portal Pressure; Recurrence; Spain | 2017 |
Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Secondary Prevention; Venous Pressure | 2009 |
Adding banding ligation is effective as rescue therapy to prevent variceal rebleeding in haemodynamic non-responders to pharmacological therapy.
Topics: Acute Disease; Aged; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Secondary Prevention; Somatostatin; Treatment Outcome | 2012 |
Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Blood Pressure; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Rate; Humans; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Male; Middle Aged; Nadolol; Survival Rate; Treatment Outcome; Vasodilator Agents | 2002 |
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Endoscopy; Esophageal and Gastric Varices; Female; Follow-Up Studies; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Propranolol; Secondary Prevention; Vasodilator Agents; Venous Pressure | 2002 |
[The randomized controlled trial of isosorbide mononitrate plus propranolol compared with propranolol alone for the prevention of variceal rebleeding].
Topics: Adult; Dizziness; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Headache; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propranolol; Treatment Outcome; Vasodilator Agents | 2002 |
Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
Topics: Aged; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide Donors; Portal Vein; Postprandial Period; Propranolol; Vasodilator Agents | 2003 |
Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Ascites; Esophageal and Gastric Varices; Female; Hemodynamics; Hepatic Encephalopathy; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Nadolol; Prognosis | 2004 |
Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
Topics: Antihypertensive Agents; Carbazoles; Carvedilol; Drug Therapy, Combination; Female; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propanolamines; Propranolol; Vasodilator Agents | 2004 |
[Comparative effectiveness of different methods of diagnosis and correction of impaired portal circulation].
Topics: Antihypertensive Agents; Humans; Hypertension, Portal; Isosorbide Dinitrate; Laser Therapy; Liver Cirrhosis; Propranolol; Ultrasonography, Doppler; Vasodilator Agents | 2004 |
Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension.
Topics: Aged; Blood Flow Velocity; Double-Blind Method; Fasting; Female; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Portal Pressure; Portal Vein; Time Factors; Treatment Outcome; Vasodilator Agents | 2004 |
[Effects of isosorbide-5-mononitrate on esophageal manometry of cirrhotic patients with esophageal varices].
Topics: Adult; Esophageal and Gastric Varices; Esophagus; Female; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Manometry; Vasodilator Agents | 2005 |
Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents | 2005 |
Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial.
Topics: Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Sclerotherapy; Secondary Prevention | 2006 |
Comparison of endoscopic variceal ligation and nadolol plus isosorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients.
Topics: Adult; Aged; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol | 2006 |
Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. GTIP Gruppo Triveneto per l'Ipertensione Portale.
Topics: Adolescent; Adult; Aged; Ascites; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Humans; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Nadolol; Venous Pressure | 1995 |
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
Topics: Administration, Oral; Adult; Aged; Blood Flow Velocity; Blood Pressure; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kidney; Liver; Liver Cirrhosis; Male; Mesenteric Artery, Superior; Middle Aged; Nadolol; Pulsatile Flow; Splanchnic Circulation; Ultrasonography, Doppler, Color; Vascular Resistance; Vasodilator Agents | 1995 |
Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
Topics: Adult; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Renal Circulation; Splanchnic Circulation; Ultrasonography, Doppler, Duplex; Vasodilator Agents | 1994 |
Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.
Topics: Adult; Aged; Azygos Vein; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Patient Compliance; Regional Blood Flow; Stimulation, Chemical; Vasodilator Agents | 1995 |
Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
Topics: Aldosterone; Analysis of Variance; Body Water; Chi-Square Distribution; Dinoprostone; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension, Portal; Inulin; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Male; Middle Aged; Portal Pressure; Propranolol; Renin; Splanchnic Circulation; Vasodilator Agents | 1994 |
Duplex Doppler ultrasonographic comparison of the effects of propranolol and isosorbide-5-mononitrate on portal hemodynamics.
Topics: Delayed-Action Preparations; Double-Blind Method; Drug Monitoring; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propranolol; Splanchnic Circulation; Ultrasonography | 1993 |
Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis.
Topics: Aged; Digestive System; Endoscopy; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Patient Dropouts; Personnel Selection; Propranolol; Prospective Studies | 1993 |
Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
Topics: Aged; Blood Pressure; Double-Blind Method; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Splanchnic Circulation; Vasodilator Agents; Venous Pressure | 1996 |
Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Hepatic Artery; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Cirrhosis; Male; Middle Aged; Nadolol; Vasodilator Agents | 1997 |
Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propranolol; Single-Blind Method; Vasodilator Agents | 1997 |
Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Double-Blind Method; Endosonography; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propranolol; Vasodilator Agents | 1997 |
Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
Topics: Adrenergic beta-Antagonists; Catheterization, Peripheral; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hepatic Veins; Humans; Hypertension, Portal; Isosorbide Dinitrate; Linear Models; Liver Cirrhosis; Male; Middle Aged; Nadolol; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasodilator Agents | 1998 |
Duplex-Doppler evaluation of the effects of propranolol and isosorbide-5-mononitrate on portal flow and splanchnic arterial circulation in cirrhosis.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Esophageal and Gastric Varices; Female; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Portal System; Propranolol; Splanchnic Circulation; Ultrasonography, Doppler, Duplex; Vasodilator Agents | 1998 |
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Randomized Controlled Trials as Topic | 2000 |
Should nitrates be used with beta blockers to prevent variceal bleeding?
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Vasodilator Agents | 2000 |
Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers.
Topics: Adrenergic beta-Antagonists; Ascites; Contraindications; Double-Blind Method; Female; Gastroesophageal Reflux; Hemodynamics; Humans; Isosorbide Dinitrate; Kidney Function Tests; Liver Cirrhosis; Male; Middle Aged; Odds Ratio; Patient Selection; Probability; Prothrombin Time; Survival Rate | 2001 |
TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial.
Topics: Adrenergic beta-Antagonists; Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Health Care Costs; Hemorrhage; Hepatic Encephalopathy; Humans; Isosorbide Dinitrate; Liver; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Prospective Studies; Quality of Life; Retreatment; Secondary Prevention; Varicose Veins | 2002 |
Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
Topics: Aged; Drug Therapy, Combination; Female; Hemodynamics; Hepatic Veins; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Propranolol; Venous Pressure | 1991 |
Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
Topics: Administration, Oral; Aged; Blood Pressure; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Cirrhosis; Male; Middle Aged; Nitroglycerin; Placebos; Time Factors | 1990 |
Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.
Topics: Aged; Blood Pressure; Drug Administration Schedule; Hemodynamics; Hepatitis B Surface Antigens; Humans; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Random Allocation | 1989 |
Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Cirrhosis; Male; Middle Aged; Splanchnic Circulation | 1989 |
18 other study(ies) available for isosorbide-5-mononitrate and Liver Cirrhosis
Article | Year |
---|---|
Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propranolol; Risk Factors; Treatment Outcome; Vasodilator Agents; Young Adult | 2009 |
The role of nitric oxide in the expression of renal aquaporin 2 in a cirrhotic rat model: does an AVP-independent mechanism exist for the regulation of AQP2 expression?
Topics: Analysis of Variance; Animals; Aquaporin 2; Biopterins; Cyclic GMP; Disease Models, Animal; Immunoenzyme Techniques; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Simvastatin; Statistics, Nonparametric; Thioacetamide | 2010 |
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
Topics: Antihypertensive Agents; Ascites; Bacterial Infections; Cohort Studies; Drug Therapy, Combination; Female; Hemodynamics; Hemorrhage; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Probability; Prognosis; Propranolol; Recurrence; Risk Factors; Survival Analysis; Time Factors; Varicose Veins; Vasodilator Agents | 2003 |
Management of cirrhosis and ascites.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents | 2004 |
The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Flow Velocity; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Portal Vein; Propranolol; Prospective Studies; Treatment Outcome; Ultrasonography, Doppler; Vasodilator Agents | 2005 |
Pharmacokinetics of isosorbide-5-mononitrate after oral and intravenous administration in patients with liver cirrhosis: first results.
Topics: Administration, Oral; Adult; Female; Humans; Infusions, Parenteral; Isosorbide Dinitrate; Kinetics; Liver Cirrhosis; Male; Middle Aged | 1983 |
The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
Topics: Adult; Aged; Azygos Vein; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Middle Aged; Vasodilator Agents | 1994 |
Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis.
Topics: Aldosterone; Ascites; Atrial Natriuretic Factor; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Renin | 1993 |
Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients.
Topics: Ascites; Atrial Natriuretic Factor; Blood Pressure; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Potassium; Renal Plasma Flow; Renin; Vasodilator Agents | 1996 |
Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.
Topics: Adult; Aged; Azygos Vein; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Hepatic Veins; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propranolol; Regional Blood Flow; Renal Circulation; Vasodilator Agents | 1998 |
Clinical vs haemodynamic response to drugs in portal hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Esophageal and Gastric Varices; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Octreotide; Propranolol; Recurrence; Sclerotherapy; Time Factors; Treatment Outcome; Vasodilator Agents | 1998 |
Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis.
Topics: Adrenergic beta-Antagonists; Coloring Agents; Delayed-Action Preparations; Drug Therapy, Combination; Female; Hepatic Veins; Humans; Indocyanine Green; Isosorbide Dinitrate; Liver; Liver Circulation; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Nadolol; Nitric Oxide Donors; Venous Pressure | 1999 |
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Prognosis; Vasodilator Agents | 2000 |
Acute and chronic effects of isosorbide-5-mononitrate administration on effective renal plasma flow and the renin-aldosterone system in cirrhotic patients.
Topics: Adult; Aged; Female; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Renal Plasma Flow; Renin-Angiotensin System; Risk Factors; Vasodilator Agents | 2000 |
[Isosorbide-5-mononitrate (mono mac) in the prevention of bleeding from esophageal varicose veins in patients with liver cirrhosis].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Treatment Outcome; Vasodilator Agents | 2001 |
Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
Topics: Aged; Blood Pressure; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Propranolol; Time Factors; Vascular Resistance | 1990 |
Effect and mechanism of action of isosorbide-5-mononitrate.
Topics: Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Portal System | 1988 |
Oral isosorbide-5-mononitrate: pharmacokinetics and clinical efficacy.
Topics: Administration, Oral; Coronary Disease; Drug Tolerance; Half-Life; Headache; Heart Failure; Humans; Isosorbide Dinitrate; Kidney Failure, Chronic; Kinetics; Liver Cirrhosis; Male | 1987 |